Zhujiang Hospital
Clinical trials sponsored by Zhujiang Hospital, explained in plain language.
-
New cell therapy trial offers hope for leukemia patients who Can't handle chemo
Disease control Not yet recruitingThis early-stage study is testing the safety and initial effectiveness of a modified CAR-T cell therapy for adults with a type of blood cancer called B-cell acute lymphoblastic leukemia/lymphoma. It is specifically for patients who are newly diagnosed but cannot tolerate the inte…
Phase: EARLY_PHASE1 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Apr 02, 2026 02:41 UTC
-
Sniffing stem cell particles: new hope for stroke brain repair?
Disease control Not yet recruitingThis is a very early safety study testing a new nasal spray for people who have had an ischemic stroke. The spray contains tiny particles from human umbilical cord stem cells, which researchers hope may help the brain heal. The study will enroll 9 patients to check if the treatme…
Phase: PHASE1 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Cancer treatment crossroads: radiation, drugs, or watchful waiting?
Disease control Not yet recruitingThis study aims to determine the best follow-up approach for patients with advanced oral or throat cancer who have already received initial drug therapy and surgery. Researchers will compare three options: standard radiation therapy, ongoing immunotherapy maintenance drugs, or si…
Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Common drug tested as potential lifesaver for sepsis organ failure
Disease control Not yet recruitingThis study is testing whether Racecadotril, a drug typically used for diarrhea, can help protect organs in patients with sepsis—a life-threatening body-wide infection. Researchers will give 44 sepsis patients either Racecadotril or a placebo (inactive substance) through a feeding…
Phase: PHASE1, PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
Race to stop clots: drug dose tested to keep ICU kidney filters flowing
Disease control Not yet recruitingThis study aims to find the best dose of a blood-thinning drug (Nafamostat) for ICU patients whose kidneys have failed and need continuous dialysis. Researchers will compare a low dose to a high dose to see which one helps the dialysis filter last longer without dangerous clottin…
Phase: PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New hope to boost blood cells for cancer patients in radiation therapy
Disease control Not yet recruitingThis study aims to see if a drug called romiplostim N01 is safe and effective at raising platelet counts in adults with solid tumors. It focuses on patients whose low platelet counts are caused by treatment regimens that include radiation therapy. The goal is to help manage this …
Phase: PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC
-
Brain zaps tested to unlock movement in trapped patients
Symptom relief Not yet recruitingThis study is testing whether two types of non-invasive brain stimulation can help improve motor function in people with locked-in syndrome. Researchers will enroll 72 patients and randomly assign them to receive either real or sham stimulation treatments for 4 weeks. The goal is…
Phase: NA • Sponsor: Zhujiang Hospital • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
New IV drug trial aims to help dialysis patients sleep better by relieving debilitating itch
Symptom relief Not yet recruitingThis study aims to see if a new intravenous (IV) drug works better than an existing oral pill at improving sleep quality for people on dialysis who suffer from severe, chronic itching caused by their kidney disease. Researchers will compare the two treatments in 50 participants o…
Phase: PHASE4 • Sponsor: Zhujiang Hospital • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Scientists hunt for Gut-Liver link in silent disease
Knowledge-focused Not yet recruitingThis study aims to understand if a specific gut bacteria, Ruminococcus gnavus, and its byproducts are linked to metabolic dysfunction-associated fatty liver disease (MAFLD). Researchers will observe and compare 200 participants, including healthy individuals and those diagnosed w…
Sponsor: Zhujiang Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Scientists investigate Gut-Liver link in cirrhosis
Knowledge-focused Not yet recruitingThis study aims to understand how changes in gut bacteria and lactate levels might relate to the worsening of liver cirrhosis. Researchers will observe 200 people, including healthy individuals and those with cirrhosis, to look for patterns. The goal is to gather knowledge about …
Sponsor: Zhujiang Hospital • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC